Humanized, nonmitogenic OKT3 antibody, huOKT3γ(Ala-Ala):: Initial clinical experience

被引:28
作者
Woodle, ES
Bluestone, JA
Zivin, RA
Jolliffe, LK
Auger, J
Xu, D
Thistlethwaite, JR
机构
[1] Univ Chicago, Dept Surg, Sect Transplantat, Ben May Inst Canc Inst, Chicago, IL 60637 USA
[2] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA
关键词
D O I
10.1016/S0041-1345(98)00278-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1369 / 1370
页数:2
相关论文
共 5 条
[1]  
ALEGRE ML, 1995, J IMMUNOL, V155, P1544
[2]  
ALEGRE ML, 1994, TRANSPLANTATION, V57, P1537
[3]  
*ORTH MULT TRANSPL, 1985, NEW ENGL J MED, V313, P357
[4]   COMPLICATIONS AND MONITORING OF OKT3 THERAPY [J].
THISTLETHWAITE, JR ;
STUART, JK ;
MAYES, JT ;
GABER, AO ;
WOODLE, S ;
BUCKINGHAM, MR ;
STUART, FP .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 11 (02) :112-119
[5]  
WOODLE ES, 1992, J IMMUNOL, V148, P2756